Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,057Revenue (TTM) $M199Net Margin (%)--Altman Z-Score--
Enterprise Value $M-41.5EPS (TTM) $-3.1Operating Margin %--Piotroski F-Score--
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yN
Price/Book--10-y EBITDA Growth Rate %--Quick Ratio--Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio--Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)--Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M48.8ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with CHRS

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

CHRS is held by these investors:



CHRS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Herman Alan C.Chief Scientific Officer 2017-02-01Sell11,333$27.37-20.9view
Viret Jean-FredericCFO 2017-01-25Sell3,900$27-19.81view
Herman Alan C.Chief Scientific Officer 2017-01-03Sell11,333$27.95-22.54view
Viret Jean-FredericCFO 2016-12-16Sell3,900$28.3-23.5view
Wahlstrom MatsDirector 2016-12-08Sell53,583$27.52-21.33view
Herman Alan C.Chief Scientific Officer 2016-12-01Sell11,333$27.4-20.99view
Viret Jean-FredericCFO 2016-11-18Sell3,900$28.19-23.2view
Herman Alan C.Chief Scientific Officer 2016-11-01Sell11,333$27.53-21.36view
Viret Jean-FredericCFO 2016-10-21Sell3,900$30.62-29.29view
Herman Alan C.Chief Scientific Officer 2016-10-03Sell11,333$25.69-15.73view

Quarterly/Annual Reports about CHRS:

News about CHRS:

Articles On GuruFocus.com
Coherus Biosciences' Humira Petition Denied Nov 08 2016 
A Look at Pharma Company Dermira's Performance Mar 27 2015 

More From Other Websites
Coherus BioSciences to Report Fourth Quarter and Full Year 2016 Financial Results on March 13th Feb 21 2017
Coherus BioSciences Announces New Employment Inducement Grants Feb 17 2017
COHERUS BIOSCIENCES, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other... Feb 13 2017
Coherus Biosciences Inc (CHRS) Could Be A Discount Entry On The Pullback Feb 08 2017
Coherus Prices Public Offering of Common Stock Feb 08 2017
Coherus Announces Proposed Public Offering of Common Stock Feb 07 2017
COHERUS BIOSCIENCES, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jan 31 2017
Coherus BioSciences Files Four Petitions for Inter Partes Review Against AbbVie’s HUMIRA®... Jan 31 2017
Coherus BioSciences, Inc. – Value Analysis (NASDAQ:CHRS) : January 27, 2017 Jan 27 2017
Coherus BioSciences, Inc. breached its 50 day moving average in a Bullish Manner : CHRS-US : January... Jan 26 2017
ETFs with exposure to Coherus BioSciences, Inc. : January 19, 2017 Jan 19 2017
Coherus Offers Positive Phase III Data on Humira Biosimilar Jan 13 2017
Coherus BioSciences Announces Positive Topline 24-Week Treatment Phase Three Results for CHS-1420... Jan 10 2017
Coherus BioSciences, Inc. breached its 50 day moving average in a Bearish Manner : CHRS-US : January... Jan 10 2017
Coherus BioSciences Management to Present at The 35th Annual J.P. Morgan Healthcare Conference Jan 04 2017
Coherus BioSciences, Inc. breached its 50 day moving average in a Bullish Manner : CHRS-US :... Dec 19 2016
Coherus BioSciences to Present at BMO – Prescriptions for Success Healthcare Conference on... Dec 07 2016
Coherus BioSciences, Inc. – Value Analysis (NASDAQ:CHRS) : December 7, 2016 Dec 07 2016
Coherus BioSciences, Inc. breached its 50 day moving average in a Bullish Manner : CHRS-US :... Dec 06 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)